Clincosm LogoSign in Get a demo

Estrogen Receptor Negative

Showing 26 - 43 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Negative, HER2/Neu Negative, Metastatic Breast Cancer Trial in Seattle (Pembrolizumab, Cisplatin)

Withdrawn
  • Estrogen Receptor Negative
  • +5 more
  • Seattle, Washington
    Seattle Cancer Care Alliance, Fred Hutch/University of Washingto
Apr 24, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
Has Results
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018

Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker

Completed
  • Basal-Like Breast Carcinoma
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +6 more
Jun 28, 2018

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Estrogen Receptor Negative Trial in Bronx, Columbus (drug, other, procedure)

Completed
  • BRCA1 Gene Mutation
  • +11 more
  • Bronx, New York
  • +2 more
Apr 20, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 29, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,

Completed
  • Estrogen Receptor Negative
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Bronx, New York
  • +5 more
Dec 21, 2017

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in New York, The Bronx (drug, procedure, other)

Terminated
Has Results
  • Estrogen Receptor Negative
  • +13 more
  • Akt Inhibitor MK2206
  • +3 more
  • New York, New York
  • +2 more
Aug 1, 2017

Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Buffalo (procedure, radiation,

Terminated
Has Results
  • Ductal Breast Carcinoma In Situ
  • +14 more
  • Therapeutic Conventional Surgery
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jun 7, 2017

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker

Withdrawn
  • Adult Solid Neoplasm
  • +12 more
  • Hsp90 Inhibitor AT13387
  • +3 more
  • (no location specified)
Jul 22, 2016

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Boston (Laboratory Biomarker Analysis,

Completed
Has Results
  • Estrogen Receptor Negative
  • +5 more
  • Boston, Massachusetts
  • +1 more
Feb 23, 2016

Adult Solid Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Scottsdale, Jacksonville, Rochester (Cilengitide,

Completed
  • Adult Solid Neoplasm
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Mar 14, 2016

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Columbus (drug, other, procedure)

Terminated
  • Estrogen Receptor Negative
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 3, 2015

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (Akt Inhibitor MK2206,

Terminated
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor MK2206
  • +4 more
  • New Haven, Connecticut
  • +4 more
Aug 26, 2015

Adult Solid Tumor, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Hershey, Pittsburgh (Carboplatin, Laboratory

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Hershey, Pennsylvania
  • +2 more
May 22, 2015

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Baltimore, Ann Arbor, Detroit

Terminated
  • Estrogen Receptor Negative
  • +7 more
  • Gamma-Secretase Inhibitor RO4929097
  • +4 more
  • Baltimore, Maryland
  • +2 more
Apr 14, 2015